| Title |
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
|
|---|---|
| Published in |
Cochrane database of systematic reviews, September 2013
|
| DOI | 10.1002/14651858.cd001090.pub2 |
| Pubmed ID | |
| Authors |
Marissa M Alejandria, Mary Ann D Lansang, Leonila F Dans, Jacinto Blas Mantaring III |
| Abstract |
Mortality from sepsis and septic shock remains high. Results of trials on intravenous immunoglobulins (IVIG) as adjunctive therapy for sepsis have been conflicting. This is an update of a Cochrane review that was originally published in 1999 and updated in 2002 and 2010. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Afghanistan | 1 | 20% |
| United Kingdom | 1 | 20% |
| United States | 1 | 20% |
| Argentina | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 441 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 4 | <1% |
| United States | 2 | <1% |
| Malaysia | 1 | <1% |
| Italy | 1 | <1% |
| Switzerland | 1 | <1% |
| United Kingdom | 1 | <1% |
| Colombia | 1 | <1% |
| Japan | 1 | <1% |
| India | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 428 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 53 | 12% |
| Researcher | 50 | 11% |
| Student > Master | 49 | 11% |
| Student > Bachelor | 48 | 11% |
| Student > Ph. D. Student | 33 | 7% |
| Other | 98 | 22% |
| Unknown | 110 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 209 | 47% |
| Nursing and Health Professions | 27 | 6% |
| Agricultural and Biological Sciences | 14 | 3% |
| Social Sciences | 12 | 3% |
| Biochemistry, Genetics and Molecular Biology | 10 | 2% |
| Other | 45 | 10% |
| Unknown | 124 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2023.
All research outputs
#1,689,926
of 24,710,887 outputs
Outputs from Cochrane database of systematic reviews
#3,715
of 12,960 outputs
Outputs of similar age
#13,534
of 185,081 outputs
Outputs of similar age from Cochrane database of systematic reviews
#80
of 222 outputs
Altmetric has tracked 24,710,887 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,960 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.9. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 185,081 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 222 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.